nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—SLCO2B1—Niacin—atherosclerosis	0.324	0.381	CbGbCtD
Latanoprost—SLCO2B1—Rosuvastatin—atherosclerosis	0.276	0.324	CbGbCtD
Latanoprost—SLCO2B1—Pravastatin—atherosclerosis	0.251	0.295	CbGbCtD
Latanoprost—Cystoid macular oedema—Niacin—atherosclerosis	0.0167	0.157	CcSEcCtD
Latanoprost—Macular oedema—Niacin—atherosclerosis	0.00719	0.0675	CcSEcCtD
Latanoprost—Iloprost—PLAT—atherosclerosis	0.00432	0.838	CrCbGaD
Latanoprost—PTGFR—Small Ligand GPCRs—CNR2—atherosclerosis	0.00263	0.0701	CbGpPWpGaD
Latanoprost—Eye irritation—Lovastatin—atherosclerosis	0.00239	0.0225	CcSEcCtD
Latanoprost—Inflammation—Ezetimibe—atherosclerosis	0.00207	0.0194	CcSEcCtD
Latanoprost—Inflammation—Simvastatin—atherosclerosis	0.00197	0.0185	CcSEcCtD
Latanoprost—Hepatic function abnormal—Lovastatin—atherosclerosis	0.0017	0.0159	CcSEcCtD
Latanoprost—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00159	0.0149	CcSEcCtD
Latanoprost—Eczema—Simvastatin—atherosclerosis	0.00154	0.0145	CcSEcCtD
Latanoprost—Hepatic function abnormal—Niacin—atherosclerosis	0.00146	0.0137	CcSEcCtD
Latanoprost—Bronchitis—Rosuvastatin—atherosclerosis	0.00146	0.0137	CcSEcCtD
Latanoprost—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00144	0.0135	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDNRA—atherosclerosis	0.00142	0.0378	CbGpPWpGaD
Latanoprost—Eczema—Niacin—atherosclerosis	0.00142	0.0133	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00134	0.0125	CcSEcCtD
Latanoprost—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00131	0.0123	CcSEcCtD
Latanoprost—SLCO2B1—Transport of organic anions—ALB—atherosclerosis	0.00128	0.0342	CbGpPWpGaD
Latanoprost—Diplopia—Pravastatin—atherosclerosis	0.00125	0.0118	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00125	0.0117	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00117	0.011	CcSEcCtD
Latanoprost—Bronchitis—Simvastatin—atherosclerosis	0.00115	0.0108	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00113	0.0106	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00112	0.0105	CcSEcCtD
Latanoprost—Urinary tract infection—Lovastatin—atherosclerosis	0.00111	0.0104	CcSEcCtD
Latanoprost—Angina pectoris—Niacin—atherosclerosis	0.00107	0.0101	CcSEcCtD
Latanoprost—Bronchitis—Niacin—atherosclerosis	0.00106	0.00994	CcSEcCtD
Latanoprost—Angina pectoris—Pravastatin—atherosclerosis	0.00106	0.00991	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—atherosclerosis	0.00102	0.0273	CbGpPWpGaD
Latanoprost—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00101	0.00946	CcSEcCtD
Latanoprost—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00099	0.00928	CcSEcCtD
Latanoprost—Urinary tract infection—Pravastatin—atherosclerosis	0.00094	0.00882	CcSEcCtD
Latanoprost—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000908	0.00851	CcSEcCtD
Latanoprost—Arthralgia—Rosuvastatin—atherosclerosis	0.000898	0.00842	CcSEcCtD
Latanoprost—Erythema—Ezetimibe—atherosclerosis	0.000877	0.00822	CcSEcCtD
Latanoprost—Back pain—Lovastatin—atherosclerosis	0.000864	0.00811	CcSEcCtD
Latanoprost—Back pain—Ezetimibe—atherosclerosis	0.000848	0.00796	CcSEcCtD
Latanoprost—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000844	0.00792	CcSEcCtD
Latanoprost—Vision blurred—Lovastatin—atherosclerosis	0.000842	0.0079	CcSEcCtD
Latanoprost—Tafluprost—PTGS2—atherosclerosis	0.000838	0.162	CrCbGaD
Latanoprost—Erythema—Simvastatin—atherosclerosis	0.000836	0.00784	CcSEcCtD
Latanoprost—Vision blurred—Simvastatin—atherosclerosis	0.000788	0.00739	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000784	0.00736	CcSEcCtD
Latanoprost—Erythema—Niacin—atherosclerosis	0.000768	0.0072	CcSEcCtD
Latanoprost—Arthralgia—Lovastatin—atherosclerosis	0.000761	0.00714	CcSEcCtD
Latanoprost—Chest pain—Lovastatin—atherosclerosis	0.000761	0.00714	CcSEcCtD
Latanoprost—Discomfort—Lovastatin—atherosclerosis	0.000752	0.00705	CcSEcCtD
Latanoprost—Chest pain—Ezetimibe—atherosclerosis	0.000746	0.007	CcSEcCtD
Latanoprost—Arthralgia—Ezetimibe—atherosclerosis	0.000746	0.007	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000741	0.00695	CcSEcCtD
Latanoprost—Discomfort—Ezetimibe—atherosclerosis	0.000737	0.00692	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—HRH1—atherosclerosis	0.000736	0.0196	CbGpPWpGaD
Latanoprost—Pain—Rosuvastatin—atherosclerosis	0.000736	0.00691	CcSEcCtD
Latanoprost—Vision blurred—Niacin—atherosclerosis	0.000723	0.00679	CcSEcCtD
Latanoprost—Vision blurred—Pravastatin—atherosclerosis	0.000712	0.00668	CcSEcCtD
Latanoprost—Chest pain—Simvastatin—atherosclerosis	0.000712	0.00668	CcSEcCtD
Latanoprost—Arthralgia—Simvastatin—atherosclerosis	0.000712	0.00668	CcSEcCtD
Latanoprost—Discomfort—Simvastatin—atherosclerosis	0.000703	0.0066	CcSEcCtD
Latanoprost—Nervous system disorder—Ezetimibe—atherosclerosis	0.000702	0.00658	CcSEcCtD
Latanoprost—Skin disorder—Ezetimibe—atherosclerosis	0.000695	0.00652	CcSEcCtD
Latanoprost—Oedema—Simvastatin—atherosclerosis	0.000682	0.0064	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000665	0.00623	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRH1—atherosclerosis	0.000658	0.0175	CbGpPWpGaD
Latanoprost—Arthralgia—Niacin—atherosclerosis	0.000653	0.00613	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000652	0.00612	CcSEcCtD
Latanoprost—Dyspnoea—Lovastatin—atherosclerosis	0.00065	0.0061	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000649	0.00609	CcSEcCtD
Latanoprost—Chest pain—Pravastatin—atherosclerosis	0.000643	0.00604	CcSEcCtD
Latanoprost—Arthralgia—Pravastatin—atherosclerosis	0.000643	0.00604	CcSEcCtD
Latanoprost—Dyspnoea—Ezetimibe—atherosclerosis	0.000638	0.00598	CcSEcCtD
Latanoprost—Discomfort—Pravastatin—atherosclerosis	0.000636	0.00596	CcSEcCtD
Latanoprost—Oedema—Niacin—atherosclerosis	0.000626	0.00588	CcSEcCtD
Latanoprost—Pain—Lovastatin—atherosclerosis	0.000624	0.00585	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000622	0.00583	CcSEcCtD
Latanoprost—Oedema—Pravastatin—atherosclerosis	0.000617	0.00579	CcSEcCtD
Latanoprost—Pain—Ezetimibe—atherosclerosis	0.000612	0.00574	CcSEcCtD
Latanoprost—Pruritus—Rosuvastatin—atherosclerosis	0.000609	0.00571	CcSEcCtD
Latanoprost—Skin disorder—Niacin—atherosclerosis	0.000608	0.00571	CcSEcCtD
Latanoprost—Dyspnoea—Simvastatin—atherosclerosis	0.000608	0.00571	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Other—EDNRA—atherosclerosis	0.000585	0.0156	CbGpPWpGaD
Latanoprost—Pain—Simvastatin—atherosclerosis	0.000583	0.00547	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—atherosclerosis	0.000571	0.0152	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000571	0.00535	CcSEcCtD
Latanoprost—Dizziness—Rosuvastatin—atherosclerosis	0.000569	0.00534	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HRH1—atherosclerosis	0.000569	0.0152	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000562	0.00527	CcSEcCtD
Latanoprost—Dyspnoea—Niacin—atherosclerosis	0.000558	0.00524	CcSEcCtD
Latanoprost—Dyspnoea—Pravastatin—atherosclerosis	0.00055	0.00516	CcSEcCtD
Latanoprost—Rash—Rosuvastatin—atherosclerosis	0.000543	0.00509	CcSEcCtD
Latanoprost—Dermatitis—Rosuvastatin—atherosclerosis	0.000542	0.00509	CcSEcCtD
Latanoprost—Headache—Rosuvastatin—atherosclerosis	0.000539	0.00506	CcSEcCtD
Latanoprost—Pain—Niacin—atherosclerosis	0.000536	0.00503	CcSEcCtD
Latanoprost—Pain—Pravastatin—atherosclerosis	0.000527	0.00495	CcSEcCtD
Latanoprost—Pruritus—Lovastatin—atherosclerosis	0.000516	0.00484	CcSEcCtD
Latanoprost—Pruritus—Ezetimibe—atherosclerosis	0.000506	0.00475	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HRH1—atherosclerosis	0.000488	0.013	CbGpPWpGaD
Latanoprost—Pruritus—Simvastatin—atherosclerosis	0.000483	0.00453	CcSEcCtD
Latanoprost—Dizziness—Lovastatin—atherosclerosis	0.000482	0.00453	CcSEcCtD
Latanoprost—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—atherosclerosis	0.000476	0.0127	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—UTS2—atherosclerosis	0.000474	0.0126	CbGpPWpGaD
Latanoprost—Dizziness—Ezetimibe—atherosclerosis	0.000473	0.00444	CcSEcCtD
Latanoprost—Rash—Lovastatin—atherosclerosis	0.00046	0.00431	CcSEcCtD
Latanoprost—Dermatitis—Lovastatin—atherosclerosis	0.000459	0.00431	CcSEcCtD
Latanoprost—Headache—Lovastatin—atherosclerosis	0.000457	0.00429	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—CASR—atherosclerosis	0.000455	0.0121	CbGpPWpGaD
Latanoprost—Dizziness—Simvastatin—atherosclerosis	0.000451	0.00423	CcSEcCtD
Latanoprost—Rash—Ezetimibe—atherosclerosis	0.000451	0.00423	CcSEcCtD
Latanoprost—Dermatitis—Ezetimibe—atherosclerosis	0.000451	0.00423	CcSEcCtD
Latanoprost—Headache—Ezetimibe—atherosclerosis	0.000448	0.0042	CcSEcCtD
Latanoprost—Pruritus—Niacin—atherosclerosis	0.000443	0.00416	CcSEcCtD
Latanoprost—Pruritus—Pravastatin—atherosclerosis	0.000436	0.00409	CcSEcCtD
Latanoprost—Rash—Simvastatin—atherosclerosis	0.00043	0.00404	CcSEcCtD
Latanoprost—Dermatitis—Simvastatin—atherosclerosis	0.00043	0.00403	CcSEcCtD
Latanoprost—Headache—Simvastatin—atherosclerosis	0.000427	0.00401	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—UTS2—atherosclerosis	0.000424	0.0113	CbGpPWpGaD
Latanoprost—Dizziness—Niacin—atherosclerosis	0.000414	0.00389	CcSEcCtD
Latanoprost—Dizziness—Pravastatin—atherosclerosis	0.000408	0.00383	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CASR—atherosclerosis	0.000407	0.0108	CbGpPWpGaD
Latanoprost—Rash—Niacin—atherosclerosis	0.000395	0.00371	CcSEcCtD
Latanoprost—Dermatitis—Niacin—atherosclerosis	0.000395	0.0037	CcSEcCtD
Latanoprost—Headache—Niacin—atherosclerosis	0.000392	0.00368	CcSEcCtD
Latanoprost—Rash—Pravastatin—atherosclerosis	0.000389	0.00365	CcSEcCtD
Latanoprost—Dermatitis—Pravastatin—atherosclerosis	0.000389	0.00365	CcSEcCtD
Latanoprost—Headache—Pravastatin—atherosclerosis	0.000386	0.00363	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—HRH1—atherosclerosis	0.000371	0.00988	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL4—atherosclerosis	0.000353	0.00938	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CX3CR1—atherosclerosis	0.000352	0.00936	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—EDNRA—atherosclerosis	0.000329	0.00875	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CNR2—atherosclerosis	0.000327	0.0087	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—GHRL—atherosclerosis	0.00032	0.00853	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.000314	0.00836	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.000301	0.00802	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.000295	0.00786	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—atherosclerosis	0.000294	0.00783	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—atherosclerosis	0.000287	0.00763	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000284	0.00756	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—KNG1—atherosclerosis	0.000281	0.00749	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.00028	0.00746	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—AGTR1—atherosclerosis	0.00028	0.00744	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000272	0.00725	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCL4—atherosclerosis	0.000268	0.00715	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.000254	0.00677	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.000254	0.00677	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—atherosclerosis	0.000252	0.0067	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—atherosclerosis	0.00025	0.00666	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.000241	0.00641	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—UTS2—atherosclerosis	0.000239	0.00637	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—EDN1—atherosclerosis	0.000237	0.00631	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CX3CR1—atherosclerosis	0.000229	0.00611	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CASR—atherosclerosis	0.000229	0.00611	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CX3CL1—atherosclerosis	0.000225	0.00599	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	0.000223	0.00593	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000218	0.0058	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000218	0.0058	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000216	0.00575	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000215	0.00573	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CNR2—atherosclerosis	0.000213	0.00568	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000212	0.00565	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.000212	0.00564	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—HRH1—atherosclerosis	0.00021	0.00559	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—AGT—atherosclerosis	0.000197	0.00524	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000195	0.00519	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HRH1—atherosclerosis	0.000191	0.00507	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000186	0.00496	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000185	0.00493	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCL3—atherosclerosis	0.000183	0.00488	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—F2—atherosclerosis	0.000182	0.00484	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.000176	0.00468	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000175	0.00467	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000169	0.0045	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—EDNRA—atherosclerosis	0.000166	0.00442	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCR2—atherosclerosis	0.000166	0.00442	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.000163	0.00433	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—GHRL—atherosclerosis	0.000162	0.0043	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000157	0.00418	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000156	0.00415	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—KNG1—atherosclerosis	0.000142	0.00378	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—AGTR1—atherosclerosis	0.000141	0.00375	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCL4—atherosclerosis	0.000138	0.00367	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—UTS2—atherosclerosis	0.000135	0.0036	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00013	0.00347	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CASR—atherosclerosis	0.00013	0.00345	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000127	0.00339	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000125	0.00333	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—UTS2—atherosclerosis	0.000123	0.00327	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000122	0.00325	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CNR2—atherosclerosis	0.000121	0.00321	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00012	0.00321	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—EDN1—atherosclerosis	0.00012	0.00318	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCL5—atherosclerosis	0.000119	0.00316	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CX3CR1—atherosclerosis	0.000118	0.00313	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CASR—atherosclerosis	0.000118	0.00313	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CX3CL1—atherosclerosis	0.000115	0.00307	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HRH1—atherosclerosis	0.000113	0.003	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.00011	0.00293	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CNR2—atherosclerosis	0.000109	0.00291	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000107	0.00286	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000102	0.00272	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—AGT—atherosclerosis	9.92e-05	0.00264	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	9.64e-05	0.00257	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCL3—atherosclerosis	9.41e-05	0.00251	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CCR2—atherosclerosis	9.37e-05	0.0025	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—EDNRA—atherosclerosis	9.37e-05	0.0025	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—PLG—atherosclerosis	9.37e-05	0.00249	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—F2—atherosclerosis	9.17e-05	0.00244	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GHRL—atherosclerosis	9.13e-05	0.00243	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOA4—atherosclerosis	8.83e-05	0.00235	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	8.8e-05	0.00234	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	8.74e-05	0.00233	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	8.65e-05	0.0023	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCR2—atherosclerosis	8.51e-05	0.00227	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EDNRA—atherosclerosis	8.51e-05	0.00227	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	8.48e-05	0.00226	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—PRKCG—atherosclerosis	8.36e-05	0.00223	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GHRL—atherosclerosis	8.29e-05	0.00221	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—APOB—atherosclerosis	8.28e-05	0.0022	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCL2—atherosclerosis	8.17e-05	0.00218	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL4—atherosclerosis	8.14e-05	0.00217	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—KNG1—atherosclerosis	8.02e-05	0.00213	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AGTR1—atherosclerosis	7.97e-05	0.00212	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	7.86e-05	0.00209	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOA2—atherosclerosis	7.6e-05	0.00202	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	7.57e-05	0.00201	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KNG1—atherosclerosis	7.28e-05	0.00194	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—UTS2—atherosclerosis	7.25e-05	0.00193	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AGTR1—atherosclerosis	7.24e-05	0.00193	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LDLRAP1—atherosclerosis	7.01e-05	0.00187	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—PPARA—atherosclerosis	6.99e-05	0.00186	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CX3CR1—atherosclerosis	6.95e-05	0.00185	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CASR—atherosclerosis	6.95e-05	0.00185	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CX3CL1—atherosclerosis	6.82e-05	0.00182	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—EDN1—atherosclerosis	6.76e-05	0.0018	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CCL5—atherosclerosis	6.7e-05	0.00178	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLTP—atherosclerosis	6.59e-05	0.00175	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.55e-05	0.00174	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CNR2—atherosclerosis	6.47e-05	0.00172	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCL8—atherosclerosis	6.46e-05	0.00172	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MMP3—atherosclerosis	6.45e-05	0.00172	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	6.44e-05	0.00171	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—PRKCG—atherosclerosis	6.41e-05	0.00171	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PRKCG—atherosclerosis	6.37e-05	0.0017	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EDN1—atherosclerosis	6.14e-05	0.00163	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCL5—atherosclerosis	6.09e-05	0.00162	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PRKCG—atherosclerosis	5.79e-05	0.00154	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VWF—atherosclerosis	5.76e-05	0.00153	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOC3—atherosclerosis	5.73e-05	0.00152	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LTA4H—atherosclerosis	5.71e-05	0.00152	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCG8—atherosclerosis	5.71e-05	0.00152	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LDLR—atherosclerosis	5.69e-05	0.00152	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AGT—atherosclerosis	5.61e-05	0.00149	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CETP—atherosclerosis	5.6e-05	0.00149	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL3—atherosclerosis	5.56e-05	0.00148	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NCF1—atherosclerosis	5.32e-05	0.00142	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.19e-05	0.00138	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—F2—atherosclerosis	5.18e-05	0.00138	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AGT—atherosclerosis	5.09e-05	0.00136	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EDNRA—atherosclerosis	5.03e-05	0.00134	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCR2—atherosclerosis	5.03e-05	0.00134	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CYBA—atherosclerosis	5.01e-05	0.00133	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CG—atherosclerosis	4.96e-05	0.00132	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.94e-05	0.00131	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PLAT—atherosclerosis	4.9e-05	0.0013	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GHRL—atherosclerosis	4.9e-05	0.0013	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PARP1—atherosclerosis	4.9e-05	0.0013	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—F2—atherosclerosis	4.71e-05	0.00125	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	4.58e-05	0.00122	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCG1—atherosclerosis	4.52e-05	0.0012	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CG—atherosclerosis	4.5e-05	0.0012	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KNG1—atherosclerosis	4.3e-05	0.00114	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AGTR1—atherosclerosis	4.27e-05	0.00114	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LCAT—atherosclerosis	4.25e-05	0.00113	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—FABP4—atherosclerosis	4.25e-05	0.00113	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—PLG—atherosclerosis	4.2e-05	0.00112	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCL2—atherosclerosis	4.19e-05	0.00112	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOA4—atherosclerosis	4.17e-05	0.00111	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PLG—atherosclerosis	4.17e-05	0.00111	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP7A1—atherosclerosis	4.1e-05	0.00109	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SOCS3—atherosclerosis	3.95e-05	0.00105	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.87e-05	0.00103	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP3—atherosclerosis	3.81e-05	0.00101	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF2—atherosclerosis	3.79e-05	0.00101	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP27A1—atherosclerosis	3.79e-05	0.00101	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.71e-05	0.000988	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOB—atherosclerosis	3.68e-05	0.00098	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL8—atherosclerosis	3.65e-05	0.000972	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EDN1—atherosclerosis	3.62e-05	0.000965	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL5—atherosclerosis	3.6e-05	0.000957	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOA2—atherosclerosis	3.59e-05	0.000955	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLA2G2A—atherosclerosis	3.59e-05	0.000955	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALOX5AP—atherosclerosis	3.59e-05	0.000955	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALOX15—atherosclerosis	3.59e-05	0.000955	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCG5—atherosclerosis	3.54e-05	0.000944	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LPL—atherosclerosis	3.52e-05	0.000936	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LPA—atherosclerosis	3.42e-05	0.000911	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKCG—atherosclerosis	3.42e-05	0.00091	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SPP1—atherosclerosis	3.33e-05	0.000887	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL8—atherosclerosis	3.32e-05	0.000883	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—BGN—atherosclerosis	3.32e-05	0.000883	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOA5—atherosclerosis	3.28e-05	0.000874	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLA2G1B—atherosclerosis	3.16e-05	0.000841	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.13e-05	0.000833	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDGFB—atherosclerosis	3.08e-05	0.00082	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALOX5—atherosclerosis	3.05e-05	0.000812	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AGT—atherosclerosis	3.01e-05	0.000801	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOE—atherosclerosis	2.95e-05	0.000785	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LEP—atherosclerosis	2.95e-05	0.000785	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.94e-05	0.000782	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CAV1—atherosclerosis	2.92e-05	0.000777	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOA1—atherosclerosis	2.91e-05	0.000776	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ESR1—atherosclerosis	2.81e-05	0.000749	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—F2—atherosclerosis	2.78e-05	0.00074	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NAMPT—atherosclerosis	2.74e-05	0.000729	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LIPC—atherosclerosis	2.72e-05	0.000724	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOC3—atherosclerosis	2.7e-05	0.00072	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LDLR—atherosclerosis	2.69e-05	0.000715	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CG—atherosclerosis	2.66e-05	0.000708	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CETP—atherosclerosis	2.62e-05	0.000699	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MAPK3—atherosclerosis	2.55e-05	0.000678	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—INS—atherosclerosis	2.52e-05	0.00067	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SCARB1—atherosclerosis	2.51e-05	0.000669	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL2—atherosclerosis	2.48e-05	0.00066	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF1—atherosclerosis	2.44e-05	0.000648	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMGCR—atherosclerosis	2.37e-05	0.000632	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.33e-05	0.000619	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SERPINE1—atherosclerosis	2.31e-05	0.000616	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOS3—atherosclerosis	2.21e-05	0.000588	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCA1—atherosclerosis	2.12e-05	0.000563	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL8—atherosclerosis	1.96e-05	0.000521	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT1—atherosclerosis	1.89e-05	0.000504	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—atherosclerosis	1.86e-05	0.000496	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMOX1—atherosclerosis	1.81e-05	0.000483	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—atherosclerosis	1.77e-05	0.000472	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NFKB1—atherosclerosis	1.75e-05	0.000467	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOB—atherosclerosis	1.74e-05	0.000463	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK8—atherosclerosis	1.72e-05	0.000459	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT1—atherosclerosis	1.72e-05	0.000457	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM1—atherosclerosis	1.69e-05	0.00045	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LPL—atherosclerosis	1.66e-05	0.000442	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GPX1—atherosclerosis	1.62e-05	0.000431	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—atherosclerosis	1.59e-05	0.000424	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CD36—atherosclerosis	1.58e-05	0.00042	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT3—atherosclerosis	1.58e-05	0.000419	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK3—atherosclerosis	1.5e-05	0.000401	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTHFR—atherosclerosis	1.49e-05	0.000398	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARA—atherosclerosis	1.47e-05	0.00039	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFB1—atherosclerosis	1.46e-05	0.000389	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AGT—atherosclerosis	1.42e-05	0.000378	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOE—atherosclerosis	1.39e-05	0.00037	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CAV1—atherosclerosis	1.38e-05	0.000367	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOA1—atherosclerosis	1.38e-05	0.000366	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CG—atherosclerosis	1.26e-05	0.000334	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARG—atherosclerosis	1.21e-05	0.000323	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—INS—atherosclerosis	1.19e-05	0.000316	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—atherosclerosis	1.1e-05	0.000293	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALB—atherosclerosis	1.09e-05	0.00029	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NOS3—atherosclerosis	1.04e-05	0.000277	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT1—atherosclerosis	1.02e-05	0.00027	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS2—atherosclerosis	9.53e-06	0.000254	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKT1—atherosclerosis	4.79e-06	0.000128	CbGpPWpGaD
